Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$142,786
in 3 filings

Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-03 LEUNG GABRIEL Director Grant or award +11,610 101,109
2026-06-03 LEUNG GABRIEL Director Grant or award · Stock Option (Right to Buy) +16,999 16,999
2026-06-02 LEUNG GABRIEL Director Sale −2,945 $15.77 $46K 89,499
2025-06-04 LEUNG GABRIEL Director Grant or award +11,215 92,444
2025-06-04 LEUNG GABRIEL Director Grant or award · Stock Option (Right to Buy) +16,697 16,697
2025-06-03 LEUNG GABRIEL Director Sale −999 $17.31 $17K 81,229
2024-06-05 LEUNG GABRIEL Director Grant or award +4,053 83,192
2024-06-05 LEUNG GABRIEL Director Grant or award · Stock Option (Right to Buy) +6,229 6,229
2024-06-04 LEUNG GABRIEL Director Sale −964 $23.89 $23K 78,175
2023-06-07 LEUNG GABRIEL Director Grant or award +3,853 79,139
2023-06-07 LEUNG GABRIEL Director Grant or award · Stock Option (Right to Buy) +6,277 6,277

Page 1 of 1 · 11 trades